The protocol was evaluated for the first 30 patients. Data were collected from September 2003 to August 2004. When a patient was started on the protocol, the pharmacy clinical coordinator and the ...
Pre-medication regimen showed an infusion-related reaction rate of 22.5 percent with intravenous RYBREVANT®, a three-fold reduction from 67.4 percent historically seen with standard IRR management In ...
Androgen Deprivation Therapy Practice Patterns in High-Risk Prostate Cancer Treated With Definitive Radiotherapy: Prospective Results From a Statewide Quality Consortium The article by Smolders et al ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback